Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CyberdyneTSE:7779 +5.79%77 EV-to-EBITDA is 18.55 as of Aug. 17, 2026, which is 64% below its 10-year median of 51.75. GuruFocus rates TSE:7779 with a GF Score™ of 77/100 and a GF Value™ of 円194.18 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 513 Medical Devices & Instruments companies, Cyberdyne ranks worse than 61.4% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cyberdyne's enterprise value is 円40,361 Mil.
Cyberdyne's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was 円2,176 Mil. Therefore, Cyberdyne's EV-to-EBITDA for today is 18.55.
The historical rank and industry rank for Cyberdyne's EV-to-EBITDA or its related term are showing as below:
TSE:7779'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -22732.4 Med: 51.75 Max: 1681.49
Current: 18.55
During the past 13 years, the highest EV-to-EBITDA of Cyberdyne was 1681.49. The lowest was -22732.40. And the median was 51.75.
TSE:7779's EV-to-EBITDA is ranked worse than 61.4% of 513
companies
in the Medical Devices & Instruments industry
Industry Median: 14.95
vs TSE:7779: 18.55
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cyberdyne's share price for today is 円256.00.
Cyberdyne's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1.310.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Cyberdyne's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7779 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Cyberdyne's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cyberdyne EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cyberdyne's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Cyberdyne's EV-to-EBITDA falls into.
Cyberdyne's current Enterprise Value is 円40,361 Mil.
Cyberdyne's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,176 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cyberdyne (TSE:7779) has a EV-to-EBITDA of 18.55 as of Aug. 17, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Cyberdyne. This is 64% below median its historical median of 51.75. According to the industry distribution chart, Cyberdyne ranks #315 out of 513 companies in the Medical Devices & Instruments industry, placing it in the top 61.4%.
Is Cyberdyne's EV-to-EBITDA too high?
Cyberdyne's current EV-to-EBITDA of 18.55 is 64% below median its 10-year median of 51.75. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.95. Cyberdyne's value of 18.55 is 24.1% above this industry median. Based on the distribution chart, Cyberdyne ranks #315 out of 513 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Cyberdyne has a GF Score™ of 77/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cyberdyne's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cyberdyne ranks #315 out of 513 companies for EV-to-EBITDA. This places Cyberdyne in the lower half of its industry. The industry median EV-to-EBITDA is 14.95. Cyberdyne's value of 18.55 is 24.1% above this benchmark. While the company's 10-year median is 51.75 vs. the industry median of 14.95, Cyberdyne has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.95, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cyberdyne's current EV-to-EBITDA of 18.55 is 24.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Cyberdyne. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cyberdyne's current EV-to-EBITDA is 18.55, which is 64% below median its own 10-year median of 51.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyberdyne stock overvalued right now?
Based on GuruFocus' analysis, Cyberdyne (TSE:7779) is currently considered Significantly Overvalued. The stock's GF Value™ is 円194.18, compared to a current price of 円256.00 — trading 31.8% above its estimated fair value. The current EV-to-EBITDA is 18.55, which is 64% below median its 10-year median of 51.75 and 24.1% above the Medical Devices & Instruments industry median of 14.95. Cyberdyne's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Cyberdyne (TSE:7779), the current EV-to-EBITDA is 18.55 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cyberdyne (TSE:7779) Overvalued in 2026?
Based on GuruFocus' analysis, Cyberdyne stock appears to be overvalued.
The current stock price of 円256.00 is trading 31.8% above its estimated GF Value™ of 円194.18.
GuruFocus considers Cyberdyne to be Significantly Overvalued.
Key valuation signals for TSE:7779:
EV-to-EBITDA: 18.55 (64% below median its 10-year median of 51.75)
GF Value™: 円194.18 vs. price of 円256.00 (31.8% above fair value)
Industry Position: 24.1% above the Medical Devices & Instruments median (#315 of 513)
No single metric tells the full story. See the TSE:7779 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cyberdyne Inc is a Japanese based company engaged in the research and development of medical welfare equipment and systems. It offers equipment and systems for rehabilitation support, body function support for elderly and disabled people, rescue support in disaster sites, entertainments, and heavy labor support in factories. Its products include Hybrid Assistive Limb (HAL) for the lower limb, single joint, lumbar, Table Interface and Cleaning Robots. In addition, it also offers services in respect to medical service and non-medical service which includes HAL therapy under medical service, and Hal fit and Robo care service under non-medical service.
77GF Score
Get the complete analysis for TSE:7779
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7779 has been successfully added to your 
